Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    17664328 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Zidovudine and Lamivudine Given Once Versus Twice Daily
Condition: HIV Infections
Intervention: Drug: Lamivudine/Zidovudine

Study has passed its completion date and status has not been verified in more than two years.